ArticleSensors and actuators. B, Chemical2025
Gold Nanoprism Enhanced SERS Aptasensor for Simultaneous Detection of Thrombin and VEGF.
Article in Sensors and actuators. B, Chemical, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Aptamer-based DNA nanoswitches for multiplexed protein detection.Chemical communications (Cambridge, England) · 2026Article
- Aptamer-based DNA nanoswitches for multiplexed protein detection.bioRxiv : the preprint server for biology · 2026Article
- In situ-assembled 3D DNA network scaffolds: a synergistic strategy for the capture and non-destructive detection of circulating tumor cells.Mikrochimica acta · 2026Article
- Plasmonic ELISA for Biomarker Detection: A Review of Mechanisms, Functionalization Strategies, and Emerging Modalities.ACS applied bio materials · 2025Review
- Development of Defect-Rich WONanomaterials (Basel, Switzerland) · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Sensitive detection of disease-specific biomarkers with high accuracy is crucial for early diagnosis, therapeutic monitoring, and understanding underlying pathological mechanisms. Traditional methods, such as immunohistochemistry and enzyme-linked immunosorbent assays (ELISA), face limitations due to the complex and expensive production of antibodies. In this context, aptamers, short oligonucleotides with advantages like easy synthesis, low cost, high specificity, and stability, have emerged as promising alternatives for biomolecular sensing. In this study, we introduce a surface-enhanced Raman spectroscopy (SERS) aptasensor for the multiplexed detection of human α-thrombin and vascular endothelial growth factor (VEGF-165). By leveraging aptamer-based biorecognition elements, our approach capitalizes on the small gaps created by aptamers, generating intense electromagnetic hotspots that significantly amplify the SERS signal. This enables simultaneous detection of human α-thrombin and VEGF-165 with remarkable sensitivity (100 fM and 1 pM, respectively). Notably, we also employ a digital protocol for analyzing the obtained vibrational spectra, marking the first-time utilization of this method for such aptasensors and offering precise quantification even at ultralow concentration regimes. We envision the reported aptasensor aptamer-based spectroscopical tools for a wide range of applications in biology and medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.